[1] | Loyfer, N., Magenheim, J., Peretz, A., et al. (2023). A DNA methylation atlas of normal human cell types. Nature 613 : 355−364. DOI: 10.1038/s41586-022-05580-6. |
[2] | Mattox, A.K., Douville, C., Wang, Y., et al. (2023). The Origin of Highly Elevated cell-free DNA in healthy individuals and patients with pancreatic, colorectal, lung, or ovarian cancer. Cancer Discov. 13 : 2166−2179. DOI: 10.1158/2159-8290.CD-21-1252. |
[3] | Brusca, S.B., Elinoff, J.M., Zou, Y., et al. (2022). Plasma cell-free DNA predicts survival and maps specific sources of injury in pulmonary arterial hypertension. Circulation. 146 : 1033−1045. DOI: 10.1161/CIRCULATIONAHA.121.056719. |
[4] | Gaitsch, H., Franklin, R.J.M., and Reich, D.S. (2023). Cell-free DNA-based liquid biopsies in neurology. Brain 146 : 1758−1774. DOI: 10.1093/brain/awac438. |
[5] | Magenheim, J., Rokach, A., Peretz, A., et al. (2022). Universal lung epithelium DNA methylation markers for detection of lung damage in liquid biopsies. Eur. Respir. J. 60 : 2103056. DOI: 10.1183/13993003.03056-2021. |
Chen R., Bai J., Zhang D., et al., (2023). Next-generation liquid biopsy elucidates cfDNA origins from organ delineation to cellular population granularity. The Innovation Life 1(3), 100041. https://doi.org/10.59717/j.xinn-life.2023.100041 |
Perspectives in next-generation liquid biopsy